HR1266Referred to Committee

Combating Illicit Xylazine Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-02-12
Introduced
106
Cosponsors
HR
ⓘ
Type

Sponsor

Jimmy Panetta
Jimmy Panetta
Democrat · CA · Representative
Votes with party: 93.9% (554 recorded votes)

Full profile: /officials/P000613

Source: Congress.gov · FEC

Cosponsors (106)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2025-02-12

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

This bill would strengthen law enforcement's ability to combat the illegal drug xylazine, a powerful sedative increasingly mixed into heroin and fentanyl that poses serious health and safety risks. The legislation likely includes measures such as increased penalties for trafficking xylazine, funding for law enforcement efforts to stop its distribution, and resources to help treat people addicted to drugs containing the substance. The bill affects drug traffickers, law enforcement agencies, and people struggling with opioid addiction.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Crime and Law Enforcement
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.